Search through all our worldwide HIV and AIDS news and features, using the topics below to filter your results by subjects including HIV treatment, transmission and prevention, and hepatitis and TB co-infections.

Neurological and cognitive problems news

Show

From To
Closer Monitoring Recommended for Older Patients Treated With Dolutegravir for HIV

The maximum concentration of the integrase inhibitor dolutegravir (DTG) was significantly higher in people living with HIV who are more than 60 years old compared with younger individuals, according to new findings published in Clinical Infectious Diseases.There have been recent concerns about DTG-related neuropsychiatric toxicity, especially among older patients with HIV.

Published
11 June 2018
From
Infectious Disease Advisor
Children born with HIV on treatment experience next-to-no developmental set-backs at the age of 5

New data on the impact of different treatment strategies on the neuro-development of young children living with HIV has been released, showing normal development in all areas apart from visual perception.

Published
25 May 2018
From
AVERT
Early HIV treatment key to avoiding brain atrophy

A new study underscores the neurological consequences of exposure to HIV without antiretroviral therapy. The researchers found that the longer the duration of untreated infection, the greater the volume loss and cortical thinning in several brain regions.

Published
04 May 2018
From
Eurekalert Medicine & Health
Study Suggests That Understanding Chronic Pain Can Help Patients Manage It Better

Often, we think that medication or surgery is the only answer for chronic pain, but a new study out of the University of Alabama (not restricted to HIV-positive people) shows how some basic pain education or cognitive behavior therapy (CBT) techniques may help patients get a grip on pain, if not alleviate it entirely.

Published
22 March 2018
From
The Body Pro
HIV and Neurocognitive Disorders: Looking for Drugs that Decrease Inflammation

HAND appears to manifest pursuant to persistent central nervous system inflammation, anomalous macrophage activation, and increased oxidative stress. Researchers are interested in finding therapies that are neuroprotective and have screened thousands of compounds that are commercially available. Two compounds/classes—fluconazole and selective serotonin reuptake inhibitors—seem to protect hippocampal neurons.

Published
13 March 2018
From
Pharmacy Times
Marijuana may help HIV patients keep mental stamina longer

A chemical found in marijuana, known as tetrahydrocannabinol, or THC, has been found to potentially slow the process in which mental decline can occur in up to 50 percent of HIV patients, says a new Michigan State University study.

Published
07 February 2018
From
Michigan State University
HIV does not increase aging-related brain changes in patients on ART

Researchers said they found no evidence that HIV accelerates aging-related brain changes over a 2-year period in middle-aged patients on successful ART.

Published
16 January 2018
From
Healio
Middle-aged HIV-positive people have increased risk of 'silent' cerebral vascular disease linked to more severe health problems

Prevalence of silent cerebral small-vessel disease (CSVD) – an important precursor to more serious neurocognitive conditions – is significantly higher among middle-aged HIV-positive people compared

Published
02 January 2018
By
Michael Carter
No change in cognitive function or brain structure in people taking effective HIV treatment for 2 years

People with HIV taking antiretroviral treatment who had undetectable viral load did not suffer any loss of cognitive function or brain volume during a two-year

Published
13 November 2017
By
Keith Alcorn
Cognitive Impairment Risk Rises With Increasing Age of People With HIV

Researchers identified this advancing risk after controlling for expected cognitive decline based on age.

Published
20 October 2017
From
Poz
← First12345...16Next →

Filter by country

Community Consensus Statement on Access to HIV Treatment and its Use for Prevention

Together, we can make it happen

We can end HIV soon if people have equal access to HIV drugs as treatment and as PrEP, and have free choice over whether to take them.

Launched today, the Community Consensus Statement is a basic set of principles aimed at making sure that happens.

The Community Consensus Statement is a joint initiative of AVAC, EATG, MSMGF, GNP+, HIV i-Base, the International HIV/AIDS Alliance, ITPC and NAM/aidsmap
close

This content was checked for accuracy at the time it was written. It may have been superseded by more recent developments. NAM recommends checking whether this is the most current information when making decisions that may affect your health.

NAM’s information is intended to support, rather than replace, consultation with a healthcare professional. Talk to your doctor or another member of your healthcare team for advice tailored to your situation.